Back to MW MARSHALL WACE, LLP

LFCRLFCR
Showing 8 of 15 quarters

Position history for MWMARSHALL WACE, LLP's holdings in LIFECORE BIOMEDICAL INC

MARSHALL WACE, LLP holds 177,471 shares of LFCR (LIFECORE BIOMEDICAL INC), worth $931,724 as of 2026-Q2. The position was increased (+204.1% shares). LFCR represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$931,724

Current Shares

177,471

Total Value Change

-$57,728

Total Shares Change

-23,229

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
177,471
+204.1%
$931,7240.0%$5.25
40
2026-Q1
Decreased
58,354
-47.3%
$217,0780.0%$6.99
0
2025-Q4
Decreased
110,621
-3.0%
$904,8820.0%$8.09
0
2025-Q3
Increased
114,075
+222.7%
$839,5920.0%$7.15
40
2025-Q2
Decreased
35,352
-47.9%
$287,0580.0%$8.19
0
2025-Q1
Decreased
67,820
-49.1%
$477,4530.0%$6.85
0
2024-Q4
Decreased
133,191
-33.6%
$989,6090.0%$7.42
0
2024-Q3
Decreased
200,700
-33.1%
$989,4520.0%$4.95
0

Other major holders of LFCR: BNP PARIBAS FINANCIAL MARKETS, Russell Investments Group, Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used